SCHEMBL12011503

SCHEMBL12011503

c1ccc(Oc2ccc3c(c2)c2ccccc2c2cc(-c4c5ccccc5c(-c5ccc6ccccc6c5)c5ccccc45)c4ccccc4c32)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSTP1 P09211 2/20 0.37
▸ ALOX5 P09917 2/20 0.37
▸ BTK Q06187 1/20 0.36
▸ NPC1 O15118 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ GPR84 Q9NQS5 1/20 0.34
▸ PIM1 P11309 1/20 0.33
▸ SOS1 Q07889 1/20 0.33
▸ PGR P06401 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ MAOB P27338 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ RCE1 Q9Y256 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP11B1 P15538 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12011504 0.86 CYP11B2 (0.46) GSTP1ALOX5NPC1RAB9AL3MBTL1
SCHEMBL11428648 0.82 GSTP1 (0.50) GSTP1NPC1POLBRAB9AL3MBTL1
SCHEMBL12128597 0.81 GSTP1 (0.41) GSTP1ALOX5BTKNPC1POLB
SCHEMBL16810254 0.81 GSTP1 (0.46) GSTP1ALOX5BTKNPC1RAB9A
SCHEMBL12011506 0.79 LMNA (0.34) GSTP1NPC1RAB9AGPR84PIM1
SCHEMBL12011510 0.77 HSD17B1 (0.35) GSTP1POLBRAB9AGPR84SOS1
SCHEMBL2620617 0.77 GSTP1 (0.39) GSTP1ALOX5NPC1POLBRAB9A
SCHEMBL12011508 0.76 SMN1; SMN2 (0.41) NPC1RAB9APIM1CYP1A2CYP2C9
SCHEMBL12011507 0.76 TUBB4A (0.34) GSTP1L3MBTL1GPR84
SCHEMBL12011505 0.75 KDM4E (0.40) L3MBTL1GPR84SOS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213640-B1 BENZOCHRYSENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IDEMITSU KOSAN CO (JP) 2016-10-05 — — EP disclosed
US-8253129-B2 Benzochrysene derivative and an organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2012-08-28 — — US disclosed
US-8253129-B2 Benzochrysene derivative and an organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2012-08-28 — — US disclosed
US-20100295029-A1 BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2010-11-25 — — US disclosed
US-20100295029-A1 BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. 2010-11-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100295029-A1 BENZOCHRYSENE DERIVATIVE AND AN ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME KSR1, NRAS, RSU1 GSTP1 2677/4885ALOX5 3009/4885BTK 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback